Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?

Figure 5

OR, risk differences and related heterogeneity indices of detection rates of radiolabeled FAPI guided and ¹⁸F-FDG directed PET/CT scans for hepatic tumors.